Shares issued
As at 31st March 2024, the number of ordinary shares in issue was 74,142,147.
Significant shareholders
As at 31st March 2024, the Company has been notified of the following interests in 3% or more of the issued ordinary share capital of the Company.
| No of ordinary shares | % | |
| Balderton Capital III, LP | 6,813,196 | 9.19 |
| Mr Timothy Brian Bunting | 4,856,717 | 6.55 |
| Blind Trust (Richard Sharp) | 4,447,000 | 6.00 |
| Genostics Company Ltd | 3,266,770 | 4.41 |
| MI Chelverton UK Equity Growth Fund | 3,007,500 | 4.06 |
Director shareholdings
| No of shares | No of share options | No of warrants | |
|---|---|---|---|
| Alistair Macdonald | 55,555 | 619,641 | – |
| Martin Gouldstone | 36,023 | 589,971 | – |
| John Goold | 1,150,000 | – | – |
Voting rights
As at 31st March 2024, the Company has been notified of the following holdings of 3% or more of the voting right in the Company.
| No of voting rights | % | |
| Balderton Capital III, LP | 6,813,196 | 9.19 |
| Mr Timothy Brian Bunting | 4,856,717 | 6.55 |
| Blind Trust (Richard Sharp) | 4,447,000 | 6.00 |
| Spreadex LTD | 4,419,057 | 5.96 |
| Genostics Company Ltd | 3,266,770 | 4.41 |
| MI Chelverton UK Equity Growth Fund | 3,007,500 | 4.06 |
Shares not in public hands
In accordance with the definition in the AIM Rules for Companies and insofar as it is aware, as at 31st March 2024, 4.25% of the Company’s AIM securities was not in public hands.
Page last updated: 25th April 2024